[肝细胞癌经动脉化疗栓塞术（TACE）后的并发症 - 肝细胞癌经动脉化疗栓塞术（TACE）后的并发症] - Suppr | 超能文献

[Complications after TACE in HCC - complications after transarterial chemoembolization (TACE) in hepatocellular carcinoma].

作者信息

Schneeweiß S, Horger M, Ketelsen D, Ioanoviciu S D

出版信息

Rofo. 2015 Feb;187(2):79-82. doi: 10.1055/s-0034-1369532. Epub 2015 Jan 28.

DOI:10.1055/s-0034-1369532

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Complications after TACE in HCC - complications after transarterial chemoembolization (TACE) in hepatocellular carcinoma].[肝细胞癌经动脉化疗栓塞术（TACE）后的并发症 - 肝细胞癌经动脉化疗栓塞术（TACE）后的并发症]

Rofo. 2015 Feb;187(2):79-82. doi: 10.1055/s-0034-1369532. Epub 2015 Jan 28.

2

Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.肝细胞癌患者经动脉化疗栓塞术后急性肾损伤的发生率、危险因素及预后：一项前瞻性队列研究

Indian J Cancer. 2015 Feb;51 Suppl 2:e3-8. doi: 10.4103/0019-509X.151984.

3

Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术后肝细胞癌的经动脉化疗栓塞术

Acta Radiol. 2012 Jun 1;53(5):545-50. doi: 10.1258/ar.2012.110476. Epub 2012 Apr 30.

4

Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.经肝动脉化疗栓塞术治疗肝细胞癌合并肾功能不全的患者。

J Clin Gastroenterol. 2010 Sep;44(8):e171-7. doi: 10.1097/MCG.0b013e3181c88235.

5

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.同期经动脉化疗栓塞和索拉非尼治疗不可切除肝细胞癌的 II 期研究。

J Hepatol. 2012 Jun;56(6):1336-42. doi: 10.1016/j.jhep.2012.01.006. Epub 2012 Feb 4.

6

Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma.严重程度和进展时间可预测肝细胞癌对经动脉化疗栓塞的耐药性。

J Gastroenterol Hepatol. 2012 Jun;27(6):1051-6. doi: 10.1111/j.1440-1746.2011.06963.x.

7

Assessment and monitoring of liver function by ¹³C-aminopyrine breath test after selective transarterial chemoembolisation of hepatocellular carcinoma.肝细胞癌选择性经动脉化疗栓塞术后通过¹³C-氨基比林呼气试验评估和监测肝功能

Z Gastroenterol. 2015 Jan;53(1):21-7. doi: 10.1055/s-0034-1385230. Epub 2015 Jan 16.

8

Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.超选择性经动脉化疗栓塞与肝切除术治疗肝功能 Child-Pugh 分级为 A 的可切除早期肝细胞癌。

Eur J Radiol. 2012 Mar;81(3):466-71. doi: 10.1016/j.ejrad.2010.12.058. Epub 2011 Mar 3.

9

Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.经动脉重复化疗栓塞术治疗门静脉侵犯型肝细胞癌的再评估

J Gastroenterol Hepatol. 2009 May;24(5):806-14. doi: 10.1111/j.1440-1746.2008.05728.x. Epub 2009 Jan 13.

10

Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.经动脉化疗栓塞作为初始治疗方案用于 BCLC B 期 HBV 相关肝细胞癌的合理性和有效性。

Liver Int. 2014 Apr;34(4):612-20. doi: 10.1111/liv.12307. Epub 2013 Sep 13.

引用本文的文献

1

Efficacy and safety of transcatheter arterial chemoembolization combined with sorafenib and sintilimab in the treatment of unresectable hepatocellular carcinoma.经动脉化疗栓塞联合索拉非尼和信迪利单抗治疗不可切除肝细胞癌的疗效与安全性

Am J Transl Res. 2024 Dec 15;16(12):7849-7858. doi: 10.62347/KNIV1276. eCollection 2024.

2

Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.经动脉化疗栓塞联合微波消融与单纯经动脉化疗栓塞治疗大的单发或多结节性肝细胞癌的疗效和预后因素比较。

Korean J Radiol. 2018 Mar-Apr;19(2):237-246. doi: 10.3348/kjr.2018.19.2.237. Epub 2018 Feb 22.